Navigation Links
Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity
Date:1/8/2008

Philadelphia, PA, January 8, 2008 Schizophrenia is a developmental disorder with a large genetic component contributing to increased risk. Available antipsychotic medications treat some of the symptoms of schizophrenia, but are typically effective in only a subset of patients. Unfortunately, it is difficult to predict the effectiveness of a specific drug in any given individual with schizophrenia. John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medicine and the VA Connecticut Healthcare System, notes that in this era of medicine, the selection of particular antipsychotic medications for particular patients with schizophrenia is more art than science. We have been seeking objective guides, perhaps biological tests, which would inform this process. A new study published in the January 1st issue of Biological Psychiatry provides some interesting data to aid in that goal.

The authors report that differential effectiveness of antipsychotic treatment was predicted, in a subset of patients with schizophrenia, by variants of the gene encoding for the regulator of G-protein signaling 4 (RGS4), a protein that regulates the functional consequences of activating neurotransmitter receptors. Dr. Daniel Campbell, corresponding author for this article, explains these results: By applying genetic analysis to the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness, we show that variants in a specific gene, RGS4, predict the effectiveness of different antipsychotic treatments. Our results also indicate that the predictive power of the RGS4 genetic variants differed between patients of self-reported African and European ancestry, and thus emphasize the importance of including multiple ethnic groups in a study.

The authors importantly note that their results will require replication, but the findings indicate that RGS4 contributes to both the severity of schizophrenia symptoms a
'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...from heart attacks. But to do that they have to pr...arlier this year, a team led by William Maisel at ...al radio transmitter could be used to modify wirel...t, 22 March, p 23). Doctors normally use these si...but a malicious hacker could reprogram the pacemak...
(Date:8/20/2008)... (CAMH) is proud to announce a landmark investment...ation (CFI) into research that will propel the und... of mental illness and addiction to the next level...cale Institutional Endeavours component of CFI,s R...our scientific strengths, and transform lives with...
(Date:8/20/2008)...ve found a way to convert ethanol and other biofue...yst makes hydrogen from ethanol with 90 percent yi...ive ingredients. , Umit Ozkan, professor of chem...iversity, said that the new catalyst is much less ...orld, because it does not contain precious metals,...
(Date:8/19/2008)...oring bran flakes; it can also preserve important ...Institute of Standards and Technology (NIST) have ... for evaluating the sugars pharmaceutical companie...om temperature. The group presented their findings...Meeting and Exposition. , Protein-based drugs su...
Breaking Biology News(10 mins):How to stop a new type of heart attack 2Large-scale investment catapults CAMH's mental illness and addiction research forward 2A better way to make hydrogen from biofuels 2A better way to make hydrogen from biofuels 3Candy-coating keeps proteins sweet 2Vaccine for Ebola virus 2664 1Vaccine for Ebola virus 2664 2Increased Heart Risk Seen for Retired NFL Players 15469 1Increased Heart Risk Seen for Retired NFL Players 15469 2Major international collaboration offers new clues to genetics of type 2 diabetes 2662 1Major international collaboration offers new clues to genetics of type 2 diabetes 2662 2Major international collaboration offers new clues to genetics of type 2 diabetes 2662 3Comparison of anticoagulants for angioplasty show similar outcomes 15466 1Comparison of anticoagulants for angioplasty show similar outcomes 15466 2
...shows that statins, which are typically used as an...ation of the hepatitis C virus (HCV). They could r...feron. These findings are published in the July 20...e American Association for the Study of Liver Dise...Inc., Hepatology is available online via Wiley Int...
...uard turned traitor, a protein whose regular job i...me cases, join forces with another protein to do t... new research at the University of Minnesota. The ...damage, for example, from ultraviolet light, and a... can become dysfunctional or cancerous. The protei...
...hers report that thousands of genes behave differe...thing never detected to this degree. Published in...eds light on why the same disease often strikes ma...ay respond differently to the same drug. , "We pr...s vary in their relationship to different diseases...
...artment of Energy (DOE) today released an ambitiou...losic ethanol as an alternative to gasoline. The ...s in biotechnology that have made cost-effective p...lant fiber, an attainable goal. The report outlin...hnologies to transform cellulosic ethanol--a renew...
Other Biology News:Statins stop hepatitis C virus from replicating 2University of Minnesota researchers take new look at cellular suicide 2UCLA study finds same genes act differently in males and females 2UCLA study finds same genes act differently in males and females 3DOE publishes research roadmap for developing cleaner fuels 2
(Date:8/21/2008)... NEW YORK, MUNICH, Germany and AMSTERDAM, Neth...thcare and SpePharm Holding, B.V., the,pan-Europea...d that they,have entered into a euro 10 million re...fund SpePharm,s acquisition of Dantrium(R) for Eur...le Pharmaceuticals. At the same,time, TVM Capital,...
(Date:8/20/2008)... VIENNA, Va., Aug. 20 /PRNewswire-USNewswire/ ...0 ranking of the fastest-growing private companies...T) services provider,MicroTech, ranks No. 285 on ... 2008 Inc. 500 list measures revenue growth from 2...U.S.-based, privately held, independent -,no subsi...
(Date:8/20/2008)... INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-First... announced that it has completed the acquisition,o...n Diego-based,biotechnology company focused on dru...y. The completion of the deal followed today,s Spe...SGX stockholders voted in,favor of the merger agre...
(Date:8/20/2008)... Growth Fueled by Popularity with Seniors and ... Marketing, CAMBRIDGE, Mass., Aug. 20 /PRNewswi...hole Health (SWH), a voluntary health care plan fo...ng private company in the,United States., Part of...rowing,companies, SWH had revenue growth of 31,000...
Breaking Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3
... about the size and growth of the medical device i...week,s column will focus on the leading players in...mment on some trends from this table, here are a c... here is the major part of the diagnostics busines...h includes clinical and molecular diagnostics. Thi...
La Crosse, Wis. - Firstlogic, Inc., announced today an expansion of its OEM partnership with Informatica Corp. of Redwood City, Calif., involving Firstlogic,s Data Quality Link for Informatica. , ,
...tics, Inc., has become is the first seed lab in th...ccredited Seed Lab (ASL) program, administered by...), the company reported Tuesday. , , BioDiagnostic...n testing services. , ,The ASL Program is a volun...aboratories. Seed testing laboratories, which meet...
...stems, Inc. has received FDA approval to market i...nced Tuesday. It will start marketing the system d... intended to monitor physiological parameters of p...ign allows a variety of optional configurations th... around the world. , ,Criticare designs, manufactu...
Other Biology Technology:Midwest plays key role in developing new medical device companies 2Midwest plays key role in developing new medical device companies 3
Rabbit polyclonal to Shigella Immunogen: Mixture of S. boydii, S. flexneri & S. dysenteriae.
...n cullin genes (CUL-1, -2, -3, -4a, -4b, and -5), ...-3 is proposed to be a part of E3 protein-ubiqutin...and targets it for ubiquitination, which leads to ...vator of cdk2, which leads the cell to S phase. Cu...
...ludes interface cable to S2000; can be mounted wit... The LS-450 Blue LED Pulsed Light Source is an L...t at 470 nm -- the blue region -- for fluorescence... Ocean Optics spectrometers configured for fluore...
Clear amber to slightly cloudy liquid. Yellow, oily, bacterial suspension. Contains 10 vials per set, each containing 10 ml of Freund's complete adjuvant homogenized in the following proportions by
Biology Products: